Fernwood Investment Management, LLC Denali Therapeutics Inc. Transaction History

Fernwood Investment Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$15.83 - $23.35 $79,150 - $116,750	5,000 New	5,000 $102,000
Q3 2021 Oct 28, 2021	SELL	$48.48 - $78.23 $145,440 - $234,690	-3,000 Closed	0 $0
Q2 2021 Aug 05, 2021	BUY	$50.3 - $78.44 $150,900 - $235,320	3,000 New	3,000 $235,000
Q1 2021 May 06, 2021	SELL	$53.8 - $81.53 $161,400 - $244,590	-3,000 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$36.89 - $93.56 $110,670 - $280,680	3,000 New	3,000 $251,000

227

119M

60.6K

48.4K

Ticker DNLI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 134,174,000
Market Cap $2.88B
Description
Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...

Get notified when there are updates to the investment portfolio of Fernwood Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Fernwood Investment Management, LLC with notifications on news.